Jialei Hua
YOU?
Author Swipe
View article: Featured Cover
Featured Cover Open
The cover image is based on the article Glutaminase‐1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells by Changsen Bai et al., https://doi.org/10.1111/cpr.70…
View article: FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening
FBLN2 promoter hypermethylation: a negative prognostic biomarker and anti-PD-1 response predictor in clear cell renal cell carcinoma via high-throughput CpG Island screening Open
View article: Glutaminase‐1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells
Glutaminase‐1 Mediated Glutaminolysis to Glutathione Synthesis Maintains Redox Homeostasis and Modulates Ferroptosis Sensitivity in Cancer Cells Open
Glutaminase‐1 (GLS1) has garnered considerable interest as a metabolic target in cancer due to its heightened involvement and activity. However, the precise fate of glutaminolysis catalysed by GLS1 in cancer cells remains elusive. We found…
View article: FBLN2 Promoter Hypermethylation: A Negative Prognostic Biomarker and Anti-Pd-1 Response Predictor in Clear Cell Renal Cell Carcinoma Via High-Throughput Cpg Island Screening
FBLN2 Promoter Hypermethylation: A Negative Prognostic Biomarker and Anti-Pd-1 Response Predictor in Clear Cell Renal Cell Carcinoma Via High-Throughput Cpg Island Screening Open
View article: CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation
CYB561 promotes HER2+ breast cancer proliferation by inhibiting H2AFY degradation Open
View article: ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression
ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor progression Open
View article: ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor cell invasion
ZNF133 is a potent suppressor in breast carcinogenesis through dampening L1CAM, a driver for tumor cell invasion Open
Background Because of the complexity and heterogeneity, therapeutic effect of breast cancer varies in each subtype, which is classified based on the molecular markers for estrogen or progesterone receptors and human epidermal growth factor…
View article: High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses Open
Objective: The purpose of current research is to explore the function of retinoic acid-induced protein 14 (RAI14), being a reciprocal protein of carboxypeptidase N1 (CPN1), and as a biomarker for prognosis and immunoregulatory effects in b…
View article: Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer Open